Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings (MAC)

September 20, 2021 updated by: Athena Philis-Tsimikas, Scripps Whittier Diabetes Institute
This study is a cluster (clinic level) randomized pragmatic trial to compare the effectiveness of MA Health Coaching (MAC) delivered by non-clinician primary care staff (i.e., MAs) versus usual care (UC) in improving diabetes clinical control among individuals with poorly controlled type 2 diabetes mellitus (T2DM).

Study Overview

Status

Completed

Detailed Description

The study will be conducted in the primary care environments of two distinct, yet representative healthcare systems in San Diego County: Neighborhood Healthcare (a San Diego County FQHC system and designated Patient-Centered Medical Home, serving predominantly ethnic minority, low income patients) and Scripps (a large, non-profit, private insurance-based health system, serving predominantly Caucasian, middle-to-higher income patients). Six hundred patients at intervention (n=2; patient N=300) and control (n=2; patient N=300) clinics, aged 18 and older, with T2DM, and glycosylated hemoglobin (HbA1c) ≥ 8.0%, and/or low-density lipoprotein cholesterol (LDL-C) ≥ 100 mg/dL, and/or systolic blood pressure (SBP) ≥ 140 within the last 60 days, will be identified and enrolled using electronic health records (EHRs). Primary clinical outcomes of HbA1c, LDL-C, and SBP assessed as part of quarterly (or annual, for LDL-C), standard-of-care medical visits will be extracted from EHRs over 12 months. Changes in patient-reported behavioral (diabetes self-care) and psychosocial (quality of life, patient activation) outcomes will be evaluated via telephone assessment in a subset of intervention and control (N=300 total) participants at baseline, month 6, and month 12. A thorough process evaluation will be conducted to establish reach, acceptability/feasibility, adoption/maintenance, and fidelity of the intervention and will integrate patient, MA, and primary care provider perspectives. Cost-effectiveness will also be examined from the health system perspective. Principles of community engaged research were incorporated in intervention and study planning and will be sustained throughout the research period.

Study Type

Interventional

Enrollment (Actual)

602

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • La Jolla, California, United States, 92121
        • Scripps Whittier Diabetes Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Must be a patient at selected Scripps or Neighborhood Healthcare clinic,
  2. Must be age 18 years or older,
  3. Must have a T2DM diagnosis,
  4. Must show evidence of poor clinical control, defined as HbA1c ≥ 8% and/or LDL-C ≥ 100 mg/dL, and/or SBP ≥ 140 mmHg.

Exclusion Criteria:

None as this is a pragmatic trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group: MA Health Coaching
Patients in the intervention group will receive the "MA Health Coaching" intervention during their primary care visits, as well a follow-up calls to encourage/monitor progress and offer support.
One-on-one behavioral health screening and tailored intervention by the MA health coach with patients who have type 2 diabetes.
Other Names:
  • MAC
No Intervention: Usual Care
Patients in this group will receive "treatment as usual" during their primary care visits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Glycosylated Hemoglobin (Hba1c); % units
Time Frame: 12 months
12 months
Low-density lipoprotein-cholesterol (LDL-c); mg/dL units
Time Frame: 12 months
12 months
Systolic blood pressure (SBP); mmHg units
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Summary of Diabetes Self-Care Activities (SDSCA) - patient-reported outcome
Time Frame: 12 months
12 months
Patient Activation Measure (PAM) - patient-reported outcome
Time Frame: 12 months
12 months
Patient Reported Outcomes Measurement Information System (PROMIS) General Health Scale - patient-reported outcome
Time Frame: 12 months
12 months
Patient Assessment of Care for Chronic Conditions (PACIC) - patient-reported outcome
Time Frame: 12 months
12 months
Morisky Medication Adherence Scale (MMAS) - patient-reported outcome
Time Frame: 12 months
12 months

Other Outcome Measures

Outcome Measure
Time Frame
Cost-effectiveness using the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Linda Gallo, PhD, San Diego State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2016

Primary Completion (Actual)

April 19, 2020

Study Completion (Actual)

April 19, 2020

Study Registration Dates

First Submitted

November 30, 2015

First Submitted That Met QC Criteria

December 28, 2015

First Posted (Estimate)

December 31, 2015

Study Record Updates

Last Update Posted (Actual)

September 27, 2021

Last Update Submitted That Met QC Criteria

September 20, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus (T2DM)

Clinical Trials on Medical Assistant Health Coaching

Subscribe